Skip to main content
logo
Goldline Pharmaceutical Limited (BOM:544759)
India flag India · Delayed Price · Currency is INR
40.14
+1.24 (3.19%)
At close: Aug 25, 2026

Goldline Pharmaceutical Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.640.641.081.421.841.50
Debt / EBITDA Ratio
1.301.301.802.564.496.05
Debt / FCF Ratio
3.323.323.716.148.44-
Net Debt / Equity Ratio
0.600.600.961.321.831.48
Net Debt / EBITDA Ratio
1.211.211.592.384.465.97
Net Debt / FCF Ratio
3.113.113.295.708.40-
Asset Turnover
1.131.131.141.111.001.20
Inventory Turnover
1.731.731.520.951.082.67
Quick Ratio
1.381.381.011.020.971.18
Current Ratio
2.152.151.981.921.872.37
Return on Equity (ROE)
33.60%33.60%31.27%26.26%4.01%4.86%
Return on Assets (ROA)
15.50%15.50%15.00%12.35%7.06%5.17%
Return on Invested Capital (ROIC)
24.35%24.35%22.64%17.14%8.49%7.26%
Return on Capital Employed (ROCE)
40.80%40.80%40.90%32.80%21.50%12.90%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Payout Ratio
5.27%5.27%7.58%12.00%84.49%-
Buyback Yield / Dilution
-15.11%--14.95%-0.04%-0.09%0.49%